JMS Bartlett

933 total citations
14 papers, 82 citations indexed

About

JMS Bartlett is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, JMS Bartlett has authored 14 papers receiving a total of 82 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 8 papers in Cancer Research and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in JMS Bartlett's work include Breast Cancer Treatment Studies (8 papers), Advanced Breast Cancer Therapies (4 papers) and Estrogen and related hormone effects (2 papers). JMS Bartlett is often cited by papers focused on Breast Cancer Treatment Studies (8 papers), Advanced Breast Cancer Therapies (4 papers) and Estrogen and related hormone effects (2 papers). JMS Bartlett collaborates with scholars based in United Kingdom, Netherlands and Germany. JMS Bartlett's co-authors include David Cameron, M. J. Irwin, Tammy Piper, Carlos Caldas, Janet Dunn, Louise Hiller, Jean Abraham, Hager R. Ali, Elena Provenzano and Larry Hayward and has published in prestigious journals such as Cancer Research, Annals of Oncology and Journal of Clinical Pathology.

In The Last Decade

JMS Bartlett

13 papers receiving 82 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
JMS Bartlett United Kingdom 6 43 39 18 15 15 14 82
Hela Koka United States 7 58 1.3× 49 1.3× 7 0.4× 28 1.9× 25 1.7× 16 132
Christian Pohlkamp Germany 7 29 0.7× 13 0.3× 13 0.7× 27 1.8× 15 1.0× 18 151
Isabel Echavarría Spain 8 46 1.1× 82 2.1× 15 0.8× 6 0.4× 17 1.1× 14 142
Soma Kobayashi United States 5 23 0.5× 38 1.0× 11 0.6× 19 1.3× 24 1.6× 8 124
Cornelia M. Focke Netherlands 5 69 1.6× 55 1.4× 5 0.3× 19 1.3× 17 1.1× 7 99
Simona Migliozzi Italy 4 33 0.8× 21 0.5× 8 0.4× 5 0.3× 14 0.9× 7 94
Sitanshu Gakkhar Canada 5 49 1.1× 49 1.3× 12 0.7× 23 1.5× 16 1.1× 6 172
Max F. Levine United States 4 30 0.7× 25 0.6× 10 0.6× 8 0.5× 9 0.6× 12 92
Tom van den Bosch Netherlands 5 42 1.0× 50 1.3× 17 0.9× 5 0.3× 8 0.5× 11 130
Valentina A. Zavala United States 4 51 1.2× 54 1.4× 22 1.2× 3 0.2× 5 0.3× 8 118

Countries citing papers authored by JMS Bartlett

Since Specialization
Citations

This map shows the geographic impact of JMS Bartlett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by JMS Bartlett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites JMS Bartlett more than expected).

Fields of papers citing papers by JMS Bartlett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by JMS Bartlett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by JMS Bartlett. The network helps show where JMS Bartlett may publish in the future.

Co-authorship network of co-authors of JMS Bartlett

This figure shows the co-authorship network connecting the top 25 collaborators of JMS Bartlett. A scholar is included among the top collaborators of JMS Bartlett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with JMS Bartlett. JMS Bartlett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Bartlett, JMS, Keying Xu, Jacqueline Wong, et al.. (2022). 138MO Prognostic performance of Breast Cancer Index (BCI) in postmenopausal women with early-stage HR+ breast cancer in the TEAM trial. Annals of Oncology. 33. S602–S602. 5 indexed citations
2.
Ali, Hager R., A. Dariush, Jeremy Thomas, et al.. (2017). Lymphocyte density determined by computational pathology validated as a predictor of response to neoadjuvant chemotherapy in breast cancer: secondary analysis of the ARTemis trial. Annals of Oncology. 28(8). 1832–1835. 31 indexed citations
3.
Raphael, Jacques, et al.. (2016). Tumour infiltrating lymphocytes and stromal CD68 in early stage HER2 positive breast cancer. Journal of Clinical Pathology. 69(6). 552–555. 6 indexed citations
4.
Dunn, Janet, JMS Bartlett, Peter Hall, et al.. (2016). OPTIMA: a randomised feasibility study of personalised care in the treatment of women with early breast cancer. UCL Discovery (University College London). 3 indexed citations
5.
Bartlett, JMS, Lucinda Billingham, D. Dodwell, et al.. (2013). Abstract OT2-3-01: The LORIS trial: A multicentre, randomized phase III trial of standard surgery versus active monitoring in women with newly diagnosed low risk ductal carcinoma in situ. Cancer Research. 73(24_Supplement). OT2–3. 12 indexed citations
6.
Nielsen, TO, et al.. (2012). Abstract S4-6: An international Ki67 reproducibility study. Cancer Research. 72(24_Supplement). S4–6. 3 indexed citations
7.
Drake, Camilla, Tammy Piper, CJH van de Velde, et al.. (2012). Abstract S1-5: PIK3CA mutations are linked to PgR expression: a Tamoxifen Exemestane Adjuvant Multinational (TEAM) pathology study.. Cancer Research. 72(24_Supplement). S1–5. 4 indexed citations
8.
Earl, Helena, David Cameron, JMS Bartlett, et al.. (2012). Abstract OT3-3-09: ARTemis trial - randomised trial with neo-adjuvant chemotherapy for patients with early breast cancer. Cancer Research. 72(24_Supplement). OT3–3.
9.
Baneshi, Mohammad Reza, Pamela Warner, Niall Anderson, et al.. (2010). CAN BIOMARKERS IMPROVE ABILITY OF NPI IN RISK PREDICTION? A DECISION TREE MODEL ANALYSIS. Iranian Journal of Cancer Prevention. 3(2). 62–74. 3 indexed citations
10.
Bartlett, JMS. (2010). Biomarkers for the diagnosis and prediction of therapeutic response in clinical breast cancer. Breast Cancer Research. 12(S1). 2 indexed citations
11.
Bartlett, JMS, CJH van de Velde, Annette Hasenburg, et al.. (2010). Abstract P3-10-33: Mammostrat® as an Immunohistochemical Multigene Assay for Prediction of Early Relapse Risk in Postmenopausal Early Breast Cancer: Preliminary Data of the TEAM Pathology Study. Cancer Research. 70(24_Supplement). P3–10. 1 indexed citations
12.
13.
14.
Bartlett, JMS, Cassandra Brookes, Lucinda Billingham, et al.. (2009). A prospectively planned pathology study within the TEAM trial confirms that progesterone receptor expression is prognostic but is not predictive for differential response to exemestane versus tamoxifen.. Cancer Research. 69(2_Supplement). 81–81. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hela Koka Breakdown of academic impact, for papers by Christian Pohlkamp Breakdown of academic impact, for papers by Isabel Echavarría Breakdown of academic impact, for papers by Soma Kobayashi Breakdown of academic impact, for papers by Cornelia M. Focke Breakdown of academic impact, for papers by Simona Migliozzi Breakdown of academic impact, for papers by Sitanshu Gakkhar Breakdown of academic impact, for papers by Max F. Levine Breakdown of academic impact, for papers by Tom van den Bosch Breakdown of academic impact, for papers by Valentina A. Zavala
Rankless by CCL
2026